Accelerating access to medicines in a changing world.
作者信息
Kettler Hannah, Lehtimaki Susanna, Schwalbe Nina
机构信息
Seattle, United States of America (USA).
Spark Street Advisors, New York, USA.
出版信息
Bull World Health Organ. 2020 Sep 1;98(9):641-643. doi: 10.2471/BLT.19.249664. Epub 2020 Jul 8.
Abstract
摘要
相似文献
1
Accelerating access to medicines in a changing world.
Bull World Health Organ. 2020 Sep 1;98(9):641-643. doi: 10.2471/BLT.19.249664. Epub 2020 Jul 8.
2
Ensuring access to essential medicines: some economic considerations.
Spec Law Dig Health Care Law. 2003 Jul(291):9-25.
3
Essential medicines out of reach for most people.
Indian J Med Sci. 2008 Dec;62(12):520-1.
4
A global accountability mechanism for access to essential medicines.
Lancet. 2018 Dec 8;392(10163):2418-2420. doi: 10.1016/S0140-6736(18)32986-6.
5
Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.
Bull World Health Organ. 2020 Sep 1;98(9):582-582A. doi: 10.2471/BLT.20.272658.
6
Accelerating access to essential medicines in the WHO South-East Asia Region: opportunities for greater engagement and better evidence.
WHO South East Asia J Public Health. 2018 Sep;7(2):59-61. doi: 10.4103/2224-3151.239414.
7
Introductory note: The access to Essential Medicines Campaign.
Trop Med Int Health. 2001 Nov;6(11):955-6. doi: 10.1046/j.1365-3156.2001.00797.x.
8
Improving global access to medicines for non-communicable diseases.
Lancet Glob Health. 2014 Oct;2(10):e561-2. doi: 10.1016/S2214-109X(14)70189-5.
9
World pharmaceutical developments.
World Hosp Health Serv. 2002;38(2):1.
10
The morally uncomfortable global drug gap.
Clin Pharmacol Ther. 2007 Nov;82(5):610-4. doi: 10.1038/sj.clpt.6100359. Epub 2007 Sep 26.
引用本文的文献
1
Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries.
J Pharm Policy Pract. 2025 Jan 9;18(1):2436898. doi: 10.1080/20523211.2024.2436898. eCollection 2025.
2
We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis.
Health Hum Rights. 2021 Jun;23(1):119-127.
3
Increasing efficiency in vaccine Production: A primer for change.
Vaccine X. 2021 Aug;8:100104. doi: 10.1016/j.jvacx.2021.100104. Epub 2021 Jun 16.
4
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine.
NPJ Vaccines. 2021 Apr 22;6(1):63. doi: 10.1038/s41541-021-00325-4.
本文引用的文献
1
Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".
Int J Health Policy Manag. 2017 Apr 1;6(4):233-236. doi: 10.15171/ijhpm.2016.118.
Zotero 插件